Novel Biotechnology Platform Based Vaccine Manufacturing for Covid-19 and Beyond

This work presents a systematic review and analysis of the traditional vaccine manufacturing methods and the "novel" biotechnology platform based methods with a reference to the COVID-19 vaccine manufacturing scenarios.

Files

Metadata

Work Title Novel Biotechnology Platform Based Vaccine Manufacturing for Covid-19 and Beyond
Access
Penn State
Creators
  1. Vishnu Kumar
Keyword
  1. Biotechnology Platforms
  2. Vaccine Manufacturing
License In Copyright (Rights Reserved)
Work Type Research Paper
Publication Date 2021
Deposited June 28, 2021

Versions

Analytics

Collections

This resource is currently not in any collection.

Work History

Version 1
published

  • Created
  • Added Creator Vishnu Kumar
  • Added Novel Biotechnology Platform Based Vaccine Manufacturing for Covid-19 and Beyond.pdf
  • Updated License Show Changes
    License
    • https://rightsstatements.org/page/InC/1.0/
  • Published
  • Updated Keyword, Description Show Changes
    Keyword
    • Biotechnology Platforms, Vaccine Manufacturing.
    • Biotechnology Platforms, Vaccine Manufacturing
    Description
    • Healthcare experts around the world have come to a consensus that effective vaccines are necessary to end the COVID 19 pandemic. Since the traditional vaccines are unable to meet the sudden spike in vaccine demand, biopharmaceutical sector is devising modern techniques to boost the development, production, and distribution of COVID 19 vaccines in large scale with tremendous speed. This triggers the need to adopt novel vaccine based on the novel biotechnology platforms such as the viral vector and nucleic acid to outrun the rapid spread of the COVID-19 pandemic. Biotechnology platform based vaccines, which has gained a lot of attention and success during the COVID 19 pandemic, is expected t o be the future of vaccines. This article tries to give the readers a detailed overview of the evolution process of vaccines and their manufacturing right from the traditional methods to the novel biotechnology platform based methods and the need for such a transition. The work then analyzes the manufacturing of two nucleic acid based COVID-19 vaccines and provides a framework to highlight their "smartness".
    • This work presents a systematic review and analysis of the traditional vaccine manufacturing methods and the "novel" biotechnology platform based methods with a reference to the COVID-19 vaccine manufacturing scenarios.
  • Updated